行情

FMS

FMS

费森尤斯医疗
NYSE

实时行情|Nasdaq Last Sale

35.35
-0.34
-0.95%
盘后: 35.35 0 0.00% 16:05 09/16 EDT
开盘
35.29
昨收
35.69
最高
35.41
最低
35.12
成交量
17.87万
成交额
--
52周最高
44.13
52周最低
31.50
市值
207.14亿
市盈率(TTM)
17.51
分时
5日
1月
3月
1年
5年
巴克莱将“非常便宜”的全球股票添加到其抗通胀名单中
Barclays has added seven new stocks to its European value basket, which it says is well-placed to provide investors with a hedge against rising inflation.
CNBC.com · 3天前
随着全球情绪反弹,欧洲市场小幅走高;红宝石下跌 6%
European markets were cautiously higher on Friday, tracking global counterparts as sentiment rebounded following a rocky week.
CNBC.com · 6天前
更新 1-欧洲股市因科技和奢侈品的提振而上涨,但每周将下跌
reuters.com · 6天前
现场市场-加薪:从大街到华尔街
reuters.com · 09/03 10:33
纳斯达克上市后,Humacyte 的投资者增加了 2500 万美元的注资
Benzinga · 08/31 14:01
费森尤斯医疗再向 Hucyte 投资 2500 万美元
MT Newswires · 08/30 11:35
费森尤斯医疗 (FMS) 第二季度收益超过预期,同比增长
Zacks.com · 08/02 11:15
——加拿大皇家银行将费森尤斯医疗的目标价从 37 美元上调至 42 美元,维持行业表现评级
MT Newswires · 08/02 09:01
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解FMS最新的财务预测,通过FMS每股收益,每股净资产,每股现金流等数据分析费森尤斯医疗近期的经营情况,然后做出明智的投资选择。
分析师评级

4位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测FMS价格均价为40.76,最高价位45.86,最低价为35.29。
EPS
机构持股
总机构数: 266
机构持股: 2,141.91万
持股比例: 3.66%
总股本: 5.86亿
类型机构数股数
增持
54
215.82万
建仓
28
36.96万
减持
45
110.66万
平仓
20
39.43万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
医疗设施与服务
+0.50%
医疗保健提供商与服务
+0.14%
高管信息
Chairman - Supervisory/Director
Dieter Schenk
Chairman - Management/Chief Executive Officer
Rice Powell
Non-Executive Chairman
Ben Lipps
Vice Chairman - Supervisory/Independent Director
Rolf Classon
Chief Financial Officer/Management Board
Helen Giza
Vice President - Research & Development/Management Board
Olaf Schermeier
Corporate Executive
Harry De Wit
Management Board
Harry de Wit
Management Board
Frank Maddux
Management Board
Katarzyna Mazur-Hofsaess
Management Board
William Valle
Management Board
Kent Wanzek
Independent Director/Supervisory Board
William Johnston
Independent Director/Supervisory Board
Dorothea Wenzel
Supervisory Board
Deborah McWhinney
Independent Director/Supervisory Board
Pascale Witz
Supervisory Board
Gregor Zuend
Supervisory Board
Gregor Zund
公告日期
每股分红
除权日期
--
每股分红:USD 0.573191
2021/05/24
2020/08/12
每股分红:USD 0.497802
2020/08/28
2019/05/08
每股分红:USD 0.450194
2019/05/17
2018/05/10
每股分红:USD 0.427
2018/05/21
2017/05/17
每股分红:USD 0.37
2017/05/11
2016/05/16
每股分红:USD 0.313
2016/05/10
2015/05/21
每股分红:USD 0.298
2015/05/15
2014/05/19
每股分红:USD 0.368
2014/05/13
2013/05/20
每股分红:USD 0.334
2013/05/14
  • 全部
  • 财务报告
  • 内部人交易
更多
FMS 简况
Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.

微牛提供Fresenius Medical Care AG & Co. KGaA(NYSE-FMS)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的FMS股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易FMS股票基本功能。